|
1
|
Inaba H, Greaves M and Mullighan CG: Acute
lymphoblastic leukaemia. Lancet. 381:1943–1955. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luan C, Yang Z and Chen B: The functional
role of microRNA in acute lymphoblastic leukemia: Relevance for
diagnosis, differential diagnosis, prognosis, and therapy. Onco
Targets Ther. 8:2903–2914. 2015.PubMed/NCBI
|
|
3
|
Avigad S, Verly IR, Lebel A, Kordi O,
Shichrur K, Ohali A, Hameiri-Grossman M, Kaspers GJ, Cloos J,
Fronkova E, et al: miR expression profiling at diagnosis predicts
relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
Genes Chromosomes Cancer. 55:328–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pui CH and Evans WE: Treatment of acute
lymphoblastic leukemia. N Engl J Med. 354:166–178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adil SN and Usman M: Adult acute
lymphoblastic leukemia. J Pak Med Assoc. 54:4442004.PubMed/NCBI
|
|
6
|
Vorwerk P, Mohnike K, Wex H, Röhl FW,
Zimmermann M, Blum WF and Mittler U: Insulin-like growth factor
binding protein-2 at diagnosis of childhood acute lymphoblastic
leukemia and the prediction of relapse risk. J Clin Endocrinol
Metab. 90:3022–3027. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Petridou E, Dessypris N, Spanos E,
Mantzoros C, Skalkidou A, Kalmanti M, Koliouskas D, Kosmidis H,
Panagiotou JP, Piperopoulou F, et al: Insulin-like growth factor-I
and binding protein-3 in relation to childhood leukaemia. Int J
Cancer. 80:494–496. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leal JA and Lleonart ME: MicroRNAs and
cancer stem cells: Therapeutic approaches and future perspectives.
Cancer Lett. 338:174–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yi B, Piazza GA, Su X and Xi Y: MicroRNA
and cancer chemoprevention. Cancer Prev Res. 6:401–409. 2013.
View Article : Google Scholar
|
|
13
|
Ghisi M, Corradin A, Basso K, Frasson C,
Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti
A, et al: Modulation of microRNA expression in human T-cell
development: Targeting of NOTCH3 by miR-150. Blood. 117:7053–7062.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cammarata G, Augugliaro L, Salemi D,
Agueli C, La Rosa M, Dagnino L, Civiletto G, Messana F, Marfia A,
Bica MG, et al: Differential expression of specific microRNA and
their targets in acute myeloid leukemia. Am J Hematol. 85:331–339.
2010.PubMed/NCBI
|
|
15
|
Wang G, Dai F, Yu K, Jia Z, Zhang A, Huang
Q, Kang C, Jiang H and Pu P: Resveratrol inhibits glioma cell
growth via targeting oncogenic microRNAs and multiple signaling
pathways. Int J Oncol. 46:1739–1747. 2015.PubMed/NCBI
|
|
16
|
Su YC, Li SC, Wu YC, Wang LM, Chao KS and
Liao HF: Resveratrol downregulates interleukin-6-stimulated sonic
hedgehog signaling in human acute myeloid leukemia. Evid Based
Complement Alternat Med. 2013:5474302013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen BY, Kuo CH, Liu YC, Ye LY, Chen JH
and Shieh CJ: Ultrasonic-assisted extraction of the botanical
dietary supplement resveratrol and other constituents of Polygonum
cuspidatum. J Nat Prod. 75:1810–1813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang ZH, Zhang JL, Duan YL, Zhang QS, Li
GF and Zheng DL: MicroRNA-214 participates in the neuroprotective
effect of resveratrol via inhibiting α-synuclein expression in
MPTP-induced Parkinson's disease mouse. Biomed Pharmacother.
74:252–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cullberg KB, Foldager CB, Lind M,
Richelsen B and Pedersen SB: Inhibitory effects of resveratrol on
hypoxia-induced inflammation in 3T3-L1 adipocytes and macrophages.
J Funct Foods. 7:171–179. 2014. View Article : Google Scholar
|
|
20
|
Frémont L: Biological effects of
resveratrol. Life Sci. 66:663–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, et al: Cancer chemopreventive activity of resveratrol, a
natural product derived from grapes. Science. 275:218–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferry-Dumazet H, Garnier O, Mamani-Matsuda
M, Vercauteren J, Belloc F, Billiard C, Dupouy M, Thiolat D, Kolb
JP, Marit G, et al: Resveratrol inhibits the growth and induces the
apoptosis of both normal and leukemic hematopoietic cells.
Carcinogenesis. 23:1327–1333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Azimi A, Hagh MF, Talebi M, Yousefi B,
Feizi AA Hossein Pour, Baradaran B, Movassaghpour AA, Shamsasenjan
K, Khanzedeh T, Ghaderi AH, et al: Time- and
concentration-dependent effects of resveratrol on miR 15a and
miR16-1 expression and apoptosis in the CCRF-CEM acute
lymphoblastic leukemia cell line. Asian Pac J Cancer Prev.
16:6463–6468. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG and
Zhu YP: Resveratrol induces apoptosis and autophagy in T-cell acute
lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating
p38-MAPK. Biomed Environ Sci. 26:902–911. 2013.PubMed/NCBI
|
|
25
|
Ghorbani A, Zand H, Jeddi-Tehrani M,
Koohdani F, Shidfar F and Keshavarz SA: PTEN over-expression by
resveratrol in acute lymphoblastic leukemia cells along with
suppression of AKT/PKB and ERK1/2 in genotoxic stress. J Nat Med.
69:507–512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu P, Liang H, Xia Q, Li P, Kong H, Lei
P, Wang S and Tu Z: Resveratrol induces apoptosis of pancreatic
cancers cells by inhibiting miR-21 regulation of BCL-2 expression.
Clin Transl Oncol. 15:741–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adams BD, Kasinski AL and Slack FJ:
Aberrant regulation and function of microRNAs in cancer. Curr Biol.
24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schotte D, Chau JC, Sylvester G, Liu G,
Chen C, van der Velden VH, Broekhuis MJ, Peters TC, Pieters R and
den Boer ML: Identification of new microRNA genes and aberrant
microRNA profiles in childhood acute lymphoblastic leukemia.
Leukemia. 23:313–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mets E, Van der Meulen J, Van Peer G,
Boice M, Mestdagh P, Van de Walle I, Lammens T, Goossens S, De
Moerloose B, Benoit Y, et al: MicroRNA-193b-3p acts as a tumor
suppressor by targeting the MYB oncogene in T-cell acute
lymphoblastic leukemia. Leukemia. 29:798–806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scherr M, Elder A, Battmer K, Barzan D,
Bomken S, Ricke-Hoch M, Schröder A, Venturini L, Blair HJ, Vormoor
J, et al: Differential expression of miR-17~92 identifies BCL2 as a
therapeutic target in BCR-ABL-positive B-lineage acute
lymphoblastic leukemia. Leukemia. 28:554–565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mohnike KL, Kluba U, Mittler U, Aumann V,
Vorwerk P and Blum WF: Serum levels of insulin-like growth
factor-I, -II and insulin-like growth factor binding proteins −2
and −3 in children with acute lymphoblastic leukaemia. Eur J
Pediatr. 155:81–86. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang S, Li W, Sun H, Wu B, Ji F, Sun T,
Chang H, Shen P, Wang Y and Zhou D: Resveratrol elicits
anti-colorectal cancer effect by activating miR-34c-KITLG in vitro
and in vivo. BMC Cancer. 15:9692015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou C, Ding J and Wu Y: Resveratrol
induces apoptosis of bladder cancer cells via miR-21 regulation of
the Akt/Bcl-2 signaling pathway. Mol Med Rep. 9:1467–1473.
2014.PubMed/NCBI
|
|
35
|
Phuah NH and Nagoor NH: Regulation of
microRNAs by natural agents: New strategies in cancer therapies.
BioMed Res Int. 2014:8045102014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Z, Huang H, Chen P, He M, Li Y,
Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, et al: miR-196b
directly targets both HOXA9/MEIS1 oncogenes and FAS tumour
suppressor in MLL-rearranged leukaemia. Nat Commun. 3:6882012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Endo Y, Toy am a T, Takahashi S, Yoshimoto
N, Iwasa M, Asano T, Fujii Y and Yamashita H: miR-1290 and its
potential targets are associated with characteristics of estrogen
receptor α-positive breast cancer. Endocr Relat Cancer. 20:91–102.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Popovic R, Riesbeck LE, Velu CS, Chaubey
A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, et
al: Regulation of mir-196b by MLL and its overexpression by MLL
fusions contributes to immortalization. Blood. 113:3314–3322. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu J, Ji X, Zhu L, Jiang Q, Wen Z, Xu S,
Shao W, Cai J, Du Q, Zhu Y, et al: Up-regulation of microRNA-1290
impairs cytokinesis and affects the reprogramming of colon cancer
cells. Cancer Lett. 329:155–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
